Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Marianna Criscuolo, Nicola Fracchiolla, Francesca Farina, Luisa Verga, Livio Pagano & Alessandro Busca. (2023) A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation. Expert Review of Hematology 0:0, pages 1-18.
Read now
Read now
Pawel Robak & Tadeusz Robak. (2023) Immunotherapy combinations for chronic lymphocytic leukemia: advantages and disadvantages. Expert Opinion on Biological Therapy 23:1, pages 21-35.
Read now
Read now
Jennifer L. Crombie & Jennifer R. Brown. (2021) The future of antibody therapy in chronic lymphocytic leukemia. Expert Opinion on Emerging Drugs 26:3, pages 323-336.
Read now
Read now
Iwona Hus, Aleksander Salomon-Perzyński & Tadeusz Robak. (2020) The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 20:7, pages 799-812.
Read now
Read now
Abdallah Abou Zahr, Prithviraj Bose & Michael J. Keating. (2017) Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 18:9, pages 857-873.
Read now
Read now
Gilad Itchaki & Jennifer R. Brown. (2017) Lenalidomide in the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 26:5, pages 633-650.
Read now
Read now
Bruce D. Cheson, Wolfram Brugger, Gandhi Damaj, Martin Dreyling, Brad Kahl, Eva Kimby, Michinori Ogura, Eckhart Weidmann, Clemens-Martin Wendtner & Pier Luigi Zinzani. (2016) Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel – an update. Leukemia & Lymphoma 57:4, pages 766-782.
Read now
Read now
Anna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, Roberto Cairoli & Marco Montillo. (2015) Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia. Biologics: Targets and Therapy 9, pages 75-86.
Read now
Read now
Maria Chaudhry & Bruce D Cheson. (2015) What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?. Expert Review of Hematology 8:6, pages 733-742.
Read now
Read now
Articles from other publishers (16)
Jessica S. Little, Zoe F. Weiss & Sarah P. Hammond. (2021) Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies. Journal of Fungi 7:12, pages 1058.
Crossref
Crossref
Teng Fong Ng, Benedict Carnley, Celia Green, Dominic Spagnolo & Michael F. Leahy. (2020) The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil. Case Reports in Hematology 2020, pages 1-4.
Crossref
Crossref
Ugonma N. Chukwueke, Eudocia Q. Lee & Patrick Y. Wen. 2020. Central Nervous System Metastases. Central Nervous System Metastases
365
372
.
Barbara Eichhorst, Michael Hallek & Valentin Goede. (2018) Management of unfit elderly patients with chronic lymphocytic leukemia. European Journal of Internal Medicine 58, pages 7-13.
Crossref
Crossref
Rimda Wanchoo, Carolina Bernabe Ramirez, Jacqueline Barrientos & Kenar D Jhaveri. (2018) Renal involvement in chronic lymphocytic leukemia. Clinical Kidney Journal 11:5, pages 670-680.
Crossref
Crossref
Lorenzo Falchi, Alessandra Ferrajoli, Ira Jacobs & Pilar Nava-Parada. (2018) An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:8, pages 508-518.e14.
Crossref
Crossref
Gilad Itchaki & Jennifer R. Brown. (2017) Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia. Therapeutic Advances in Hematology 9:1, pages 3-19.
Crossref
Crossref
Bruce D. Cheson, Sari Heitner Enschede, Elisa Cerri, Monali Desai, Jalaja Potluri, Nicole Lamanna & Constantine Tam. (2017) Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents. The Oncologist 22:11, pages 1283-1291.
Crossref
Crossref
Krzysztof Jamroziak, Bartosz Puła & Jan Walewski. (2017) Current Treatment of Chronic Lymphocytic Leukemia. Current Treatment Options in Oncology 18:1.
Crossref
Crossref
Suguru Fukuhara & Kensei Tobinai. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia
99
122
.
Barbara Eichhorst, Michael Hallek & Valentin Goede. (2016) New treatment approaches in CLL: Challenges and opportunities in the elderly. Journal of Geriatric Oncology 7:5, pages 375-382.
Crossref
Crossref
Francisco Javier Peñalver, Julio Delgado, Javier Loscertales, Jose Luis Sastre, Asunción Peña, María Teresa Olave, Santiago Osorio, Adolfo de la Fuente, Antonio Salar, Carlos Grande, Elena Pérez Ceballos, Guillermo Debén, Asunción Echeveste, Felipe Casado, Javier de la Rubia, Juan José Lahuerta & María Victoria Mateos. (2016) Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma. European Journal of Haematology 96:5, pages 532-540.
Crossref
Crossref
Paula Cramer, Michael Hallek & Barbara Eichhorst. (2016) State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. Oncology Research and Treatment 39:1-2, pages 25-32.
Crossref
Crossref
Paula Cramer, Petra Langerbeins, Barbara Eichhorst & Michael Hallek. (2016) Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG). European Journal of Haematology 96:1, pages 9-18.
Crossref
Crossref
Brandon G. Smaglo, Dalal Aldeghaither & Louis M. Weiner. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
550
559
.
Michael Doubek, Yvona Brychtova, Anna Panovska, Ludmila Sebejova, Olga Stehlikova, Jana Chovancova, Jitka Malcikova, Jana Smardova, Karla Plevova, Pavlina Volfova, Martin Trbusek, Marek Mraz, Denisa Bakesova, Jakub Trizuljak, Marketa Hadrabova, Petra Obrtlikova, Josef Karban, Lukas Smolej, Alexandra Oltova, Eva Jelinkova, Sarka Pospisilova & Jiri Mayer. (2015) Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. American Journal of Hematology 90:5, pages 417-421.
Crossref
Crossref